Consolidation And Cost Reduction Measures Behind 112% YoY Q3 Revenue Growth For Cannabis Co. BZAM

BZAM Ltd. (CSE: BZAM) (US-OTC: BZAMF) announced its financial and operating results on Tuesday for the three and nine-month period ended Sept. 30, 2023.

BZAM Ltd. (CSE:BZAM) (OTC:BZAMF) announced its financial and operating results on Tuesday for the three and nine-month period ended Sept. 30, 2023.

The Canadian cannabis producer reported a 112% year-over-year increase in net revenue to CA$21 million ($15,4 million) in the third quarter of 2023, primarily driven by expansion in its brand and product portfolio resulting from the merger with The Green Organic Dutchman Holdings Ltd. which was completed in 2022.

As part of the final phase of its plan to unlock company-wide synergies following the merger, BZAM laid off over 90 employees at two of its facilities in British Columbia and Ontario. The company also eliminated redundant facilities, realigning its production activities across remaining sites to maximize efficiencies and reduced selling, general and administrative expenses to achieve its goal of positive EBITDA.

“In Q3 we completed our extensive post-merger facility consolidation and cost reduction program while rationalizing several low-margin SKUs, which we expect to positively impact our operating metrics going forward,” Matt Milich, the company’s CEO said on Tuesday.

Q3 2023 Financial Highlights

  • Net revenue increased 9% sequentially.
  • Gross profit totaled CA$107, 000, down from CA$997, 000 in the prior year’s period.
  • Loss from operations was CA$12.9 million, compared to CA$8.7 million for the prior quarter, and CA$12.1 million in the same quarter of last year.
  • Net loss from operations totaled roughly CA$17 million, up from CA$6.8 million in the same quarter of last year.
  • Total operating expenses were CA$13 million, up from CA$9.7 million in the prior year’s period.
  • Adjusted general and administrative expenses increased year-over-year by CA$2.5 million or 59% primarily due to the BZAM Transaction, and increased by CA$0.51 million from the prior quarter, or 8%.

Nine-Month Period Ended Sept. 30

  • Net revenue totaled CA$94.5 million, up from $44 million compared to the prior year’s period.
  • Gross profit totaled CA$4.9 million, down from CA$13.9 million in the prior year’s period.
  • Net loss from operations totaled roughly CA$101.8 million, up from CA$27 million in the same period of last year.
  • As of Sept. 30, 2023, total assets amounted to CA$172 million and total liabilities were CA$86.6 million, as compared to CA$274.4 million and CA$96.1 million, respectively, on Dec. 31, 2022.

BZAMF Price Action

BZAM’s shares traded 0.9664% lower at $0.1178 per share after the market close on Tuesday.

  • Canadian Cannabis Producer’s CA$2M Private Offering Led By Chairman & Largest Shareholder
  • BZAM Q2 Revenue Grows 66% YoY, What About Profit?
  • BZAM To Increase Ownership Of BZAM Cannabis To 84.8%
  • Did you miss the first wave of cannabis investments? Don’t make that mistake again.
    Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
    Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
    Just this year, the PotProfits portfolio has seen smoking-hot gains like:
  •  47.10% with $GTBIF
  •  40.23% with $TCNNF
  •  21.50% with $VFF
  •  But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.Don’t miss out on the green rush!

Photo: Courtesy of Elsa Olofsson on Unsplash

Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 4/20 Under New Partnership

California-based I Love Growing Marijuana (ILGM), announced on Tuesday an exclusive new partnership with cannabis genetics and breeding company, Phylos Bioscience, that brings 15 new F1 hybrid strains to home growers across legal markets nationwide. ILGM is launching half the collection of strains that are "crafted for potency, flavor, and diversity" on its website just in time for marijuana culture's high holiday on 4/20. In doing so, the company is leveraging Phylos Bioscience's cutting-edge technology and extensive genetic library, which Benzinga has learned exclusively. Ernst Rustenhoven, CEO of ILGM, commented on the new partnership. "ILGM caters to a customer base of novice and veteran home growers on the hunt for increasingly unique strains of superior genetics, and we have been seeking an innovative partner to help elevate and diversify our product offerings," Rustenhoven said. "In forging a relationship with Phylos, we are taking our seed catalog to the next level with a highly curated selection of sought-after F1 hybrid strains."

OGI